Skip to content

Pilot Study of Home Blood Pressure Control Program (eBP Control)

Pilot Study of Home Blood Pressure Control Program (eBP Control)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01387945
Acronym
eBPcontrol
Enrollment
28
Registered
2011-07-06
Start date
2010-09-30
Completion date
2012-09-30
Last updated
2016-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Hypertension

Keywords

Home blood pressure monitoring, Patient activation, Patient-centered care, Community Health Aides, Primary Health Care

Brief summary

This intervention study will evaluate the feasibility,acceptability and effectiveness of an e-health enabled model of care by randomly assigning a trained patient navigator and/or a blood pressure (BP) self-management web portal to patients with uncontrolled hypertension after a run in period with a home BP monitor (HBPM) and comparing the results on blood pressure control. We anticipate that patients receiving the combination of a patient navigator(PN)with a self-management web portal and home BP monitor will have better BP control than when the only received a home BP monitor.

Detailed description

The study will demonstrate and evaluate the feasibility and acceptability of an e-health enabled model of care for improved hypertension and elevated blood pressure control using a home blood pressure monitor (HBPM), a blood pressure (BP) self-management web portal, and a trained patient navigator. During the first or the control period, all of the participants will have access to the only the HBPM. The control period will be compared to the final or the intervention period when the participants will gain access to a trained patient navigator and the web portal. This comparison will assist in estimating the effect sizes of the HBPM plus PN plus self-management web portal to HBPM alone for each of the outcomes: patient activation, self-management activities, medication adherence, reduced clinical inertia, and improved BP control. The second of the randomization periods will allocate a patient navigator to half of the participants, while the other half will gain access to only the web portal. We will compare the effectiveness of the PN plus webportal plus HBPM to webportal plus HBPM during this second period. An evaluation of the intervention process will delineate the barriers and facilitators by the providers, participants, and patient navigators.

Interventions

BEHAVIORALHBPM+website+patient navigator

In addition to home blood pressure monitor, patient receives access to BP web portal and trained patient navigator.

Sponsors

Agency for Healthcare Research and Quality (AHRQ)
CollaboratorFED
Memorial Hospital of Rhode Island
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed w/ hypertension or elevated blood pressure, uncontrolled blood pressure at the baseline research visit according to the following risk levels: * Average risk, * SBP \>140 mmHg or DBP \> 90 mmHg; * Vascular disease (cerebrovascular disease, coronary heart disease, diabetes mellitus, peripheral vascular disease, renal insufficiency) * SBP \>130 mmHg or DBP \>80 mmHg; * Left ventricular dysfunction, * SBP 120 mmHg or DBP \>80 mmHg; * can read and understand English; must have access to internet

Exclusion criteria

* Unable to comply with protocol; * pregnancy; * secondary hypertension (e.g. renovascular); * participation in other hypertension clinical trials; * hospitalized in the past six months for diabetes, renal failure, or heart failure; * severe renal insufficiency (estimated glomerular filtration rate \< 30 mL/min); * patient already routinely using a home blood pressure monitoring device or patient not able to use HBPM device due to disability; * arm circumference larger than 17 inches determined during telephone screener, * arm circumference smaller than 9 inches measured at baseline research visit.

Design outcomes

Primary

MeasureTime frameDescription
Percent of patients at BP goalNine monthsPercentage of patients at systolic and/or diastolic blood pressure at goal at the fourth research visit (end of the study)

Secondary

MeasureTime frameDescription
Health statusNine MonthsSF-12 questionnaire, patient activation
Use of intervention toolsNine monthshome blood pressure monitor-amount of time at goal; number of times patient utilized the website
CostsNine months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026